CLINICAL TRIAL WITH TENOFOVIR VERSUS LAMIVUDINE PLUS ADEFOVIR DIPIVOXIL IN LAMIVUDINE-RESISTANT CHRONIC HEPATITIS-B PATIENTS WITH UNDETECTABLE VIRAL LOAD
Phase of Trial: Phase IV
Latest Information Update: 03 Jun 2016
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary) ; Adefovir dipivoxil; Lamivudine
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms TENOSIMP-B
- 28 May 2016 Status changed from recruiting to completed.
- 13 Apr 2014 Primary endpoint 'Sustained-virological-response-rate' has been met according to abstract published at the 49th Annual Meeting of the European Association for the Study of the Liver.
- 13 Apr 2014 Results presented at the 49th Annual Meeting of the European Association for the Study of the Liver.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History